title: [Medical abortion with mifepristone and misoprostol: study of the efficacy, somatic tolerance and perception of medical abortion].
abstract: METHODS
  This prospective study examined the efficacy and somatic tolerance as well as the perception of the different phases of medical abortion with mifepristone and misoprostol. The subjective influence of counseling and accompanying on perception and psychic sequelae was evaluated.
  
  
  METHODS
  The somatic data of the patients who had a medical abortion at Basel University Hospital of Gynecology and Obstetrics from December 1, 1999, to October 31, 2000, were identified in the case records. A questionnaire at the time of the abortion and a structured interview by telephone 6 months later were used to assess the perception of the abortion.
  
  
  RESULTS
  Abortion with mifepristone and misoprostol was successful in 95.2% of cases. Counseling and accompanying were considered supportive by 90.4 and 73.7%, respectively. The psychological workup was without problems in 95.5%.
  
  
  CONCLUSIONS
  Medical abortion with mifepristone and misoprostol was successful in 95.2%. Our concept of counseling and accompanying was well received and resulted in an uneventful psychological workup in most cases.
authors.affiliation: Universitäts-Frauenklinik, Basel, Schweiz, Switzerland. schwe4ndke@bluewin.ch
authors.forename: A
authors.initials: A
authors.lastname: Schwendke
authors.forename: M
authors.initials: M
authors.lastname: Zarkadas
authors.forename: J
authors.initials: J
authors.lastname: Alder
authors.forename: E
authors.initials: E
authors.lastname: Horner
authors.forename: J
authors.initials: J
authors.lastname: Bitzer
authors.forename: W
authors.initials: W
authors.lastname: Holzgreve
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects; D000025:Abortion, Eugenic / Q000523:psychology; D000223:Adaptation, Psychological; D000293:Adolescent; D000328:Adult; D003376:Counseling; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects; D016595:Misoprostol / Q000009:adverse effects; D017060:Patient Satisfaction; D011247:Pregnancy; D011446:Prospective Studies; D013557:Switzerland
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone